Abstract
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system. Recent studies in experimental allergic encephalomyelitis and acquired knowledge in fundamental immunology using molecular biological techniques suggest that the inactivation of T cells by anti-disease specific T cell receptor will be a specific therapy for MS. Here, I'll present the recent advances in the diagnosis and treatment of MS.